340B Drug Pricing Program
As the 2019 chair of the AHA’s Section for Small or Rural Hospitals, I can attest that AHA is stepping up in a big way to grapple with the issues that affect many rural hospitals.
The Court determined that the U.S. Department of Health and Human Services ("Agency") acted in an ultra vires fashion when it reduced the payment, in the 2018 Medicare Outpatient Prospective Payment System Rule ("OPPS Rule"), 82 Fed. Reg. at 52, 362, for drugs purchased through the 340B Program.…
This Court should reject Defendants’ attempt to re-litigate the merits of the case or, alternatively, to decide on their own if the 340B hospitals are entitled to relief and if so what that relief might be. Defendants’ proposal is nothing more than an attempt to further delay resolution of this…
A federal court should order the Department of Health and Human Services to "make whole" 340B hospitals that received reimbursement reductions resulting from the Centers for Medicare & Medicaid Services' 2018 outpatient prospective payment system rule, AHA and other hospital plaintiffs said…
A federal court should order the Department of Health and Human Services to “make whole” 340B hospitals that received reimbursement reductions resulting from the Centers for Medicare & Medicaid Services’ 2018 outpatient prospective payment system rule, AHA and other hospital plaintiffs said…
The American Hospital Association’s 2019 Public Policy Advocacy Agenda seeks to continue to positively influence the public policy environment for patients, communities and the health care field. We will work hand in hand with our members; the state, regional and metropolitan hospital associations…
On Dec. 27, the District Court for the District of Columbia issued an order in favor of the AHA and the other plaintiffs in the lawsuit to stop the Centers for Medicare & Medicaid Services' nearly 30 percent reduction in the reimbursement rate for 340B drugs as exceeding the statutory authority…